Burning Rock Biotech Limited - American Depositary Shares (BNR) closed at $12.39 on November 9, 2026, down 7.7% from the previous close, on volume of 8,396 shares (30-day average 29,849).
Data as of November 9, 2026.
No headlines found.
Burning Rock Reports Second Quarter 2026 Financial Results
Globe Newswire (Thu, 10-Sep 7:17 AM ET)
Burning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
Burning Rock Biotech Limited - American Depositary Shares trades on the NASDAQ stock market under the symbol BNR.
As of November 9, 2026, BNR stock price declined to $12.39 with 8,396 million shares trading.
BNR has a beta of 1.98, meaning it tends to be more sensitive to market movements. BNR has a correlation of 0.04 to the broad based SPY ETF.
BNR has a market cap of $130.67 million. This is considered a Micro Cap stock.
In the last 3 years, BNR traded as high as $41.72 and as low as $2.18.
BNR has underperformed the market in the last year with a return of +1.1%, while SPY returned +13.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BNR shares. However, BNR has outperformed the market in the last 3 month and 2 week periods, returning +39.5% and +4.8%, while SPY returned -1.8% and -1.0%, respectively. This indicates BNR has been having a stronger performance recently.
BNR support price is $11.85 and resistance is $14.99 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BNR shares will trade within this expected range on the day.
